Latanoprost + Timolol


Thông tin thuốc gốc
Chỉ định và Liều dùng
Ophthalmic
Ocular hypertension, Open-angle glaucoma
Adult: Available preparation:
Latanoprost 50 mcg and timolol 5 mg per mL of eye drop solution

In patients who do not adequately respond to topical β-blockers or prostaglandin analogues: Instil 1 drop into the affected eye(s) once daily.
Tương kỵ
Latanoprost: May form precipitate with thiomersal-containing eye drops.
Chống chỉ định
Reactive airway disease (e.g. existing or history of bronchial asthma, severe COPD); sinus bradycardia, sick sinus syndrome, sino-atrial block, 2nd- or 3rd-degree atrioventricular block (not controlled with a pacemaker), overt cardiac failure, cardiogenic shock; active herpes simplex keratitis or history of recurrent herpetic keratitis specifically associated with prostaglandin analogues.
Thận trọng
Patients with history of atopy or severe anaphylaxis to allergens, 1st-degree heart block, heart failure, orthostatic hypotension, severe peripheral circulatory disturbance or disorders (e.g. severe forms of Raynaud’s syndrome), mild or moderate COPD, diabetes (especially labile diabetes), hyperthyroidism, corneal diseases, other types of glaucoma (e.g. inflammatory, neovascular or chronic angle-closure glaucoma, open-angle glaucoma of pseudophakic patients, pigmentary glaucoma), closed-angle glaucoma (as monotherapy), history of herpetic keratitis, active intraocular inflammation; aphakic patients, pseudophakic patients with torn posterior lens capsule, risk factors for macular oedema; myasthenia gravis. Patients undergoing surgery.
Tác dụng không mong muốn
Significant: Choroidal detachment (post-filtration procedures), increased iris pigmentation, eyelid skin and eyelash changes (increased length, darkening and thickening of the eyelashes), anaphylactic reactions, bacterial keratitis, macular oedema (e.g. cystoid macular oedema).
Eye disorders: Eye pain or irritation (e.g. stinging, burning, itching, foreign body sensation), blepharitis, blurred vision, corneal disorder, conjunctivitis, eye hyperaemia.
Nervous system disorders: Dizziness, headache.
Skin and subcutaneous tissue disorders: Rash.
Potentially Fatal: Cardiac failure; bronchospasm (in patients with asthma).
Thông tin tư vấn bệnh nhân
Remove contact lenses before administration and reinsert after 15 minutes. This drug may cause transient blurring of vision, if affected, do not drive or operate machinery.
Chỉ số theo dõi
Monitor intraocular pressure, changes in iris colour and eyelash; systemic effects of β blockade; signs and symptoms of heart failure.
Quá liều
Symptoms: Latanoprost: Ocular irritation and conjunctival hyperaemia.
Timolol (systemic): Bradycardia, hypotension, bronchospasm and cardiac arrest.
Management: Symptomatic and supportive treatment.
Tương tác
May have potentiated effects on intraocular pressure or systemic β-blockade with oral or other topical β-adrenergic blockers.
Latanoprost: Paradoxical increase in intraocular pressure with another prostaglandin analogues.
Timolol: May have additive effects resulting in hypotension and/or notable bradycardia with oral Ca channel blockers, guanethidine, antiarrhythmics (e.g. amiodarone), digitalis glycosides, parasympathomimetics, narcotics and MAOIs. Potentiated systemic β blockade (e.g. decreased heart rate, depression) with CYP2D6 inhibitors (e.g. quinidine, fluoxetine, paroxetine). May result in mydriasis with epinephrine. May potentiate the hypertensive reaction to sudden withdrawal of clonidine. May increase the hypoglycaemic effect of anti-diabetic agents.
Tác dụng
Description: Latanoprost, a prostaglandin F analogue, is a selective prostanoid FP receptor agonist which reduces IOP by primarily increasing the uveoscleral outflow of the aqueous humour.
Timolol, a non-selective adrenergic receptor antagonist, reduces IOP by decreasing the production of aqueous humour in the ciliary epithelium.
Onset: Within 1 hour.
Latanoprost: Intraocular pressure reduction: 3-4 hours.
Timolol: Intraocular pressure reduction: 30 minutes.
Duration: Up to 24 hours.
Timolol: 24 hours.
Pharmacokinetics:
Absorption: Latanoprost: Well-absorbed through the cornea. Bioavailability: 45% (acid of latanoprost). Time to reach maximum concentration in the aqueous humour: 2 hours.
Timolol: Partly absorbed systemically. Time to reach maximum concentration in the aqueous humour: Approx 1 hour. Time to peak plasma concentration: 10-20 minutes.
Distribution: Latanoprost: Volume of distribution: Approx 0.16 L/kg (acid of latanoprost). Plasma protein binding: 87%.
Timolol: Enters breast milk.
Metabolism: Latanoprost: Primarily metabolised in the liver via fatty acid beta-oxidation.
Timolol: Extensively metabolised in the liver.
Excretion: Latanoprost: Mainly via urine (as metabolites). Elimination half-life: 17 minutes (acid of latanoprost).
Timolol: Via urine (as metabolites with some unchanged drug). Elimination half-life: Approx 6 hours.
Đặc tính

Chemical Structure Image
Latanoprost

Source: National Center for Biotechnology Information. PubChem Database. Latanoprost, CID=5311221, https://pubchem.ncbi.nlm.nih.gov/compound/Latanoprost (accessed on Jan. 22, 2020)


Chemical Structure Image
Timolol

Source: National Center for Biotechnology Information. PubChem Compound Summary for CID 33624, Timolol. https://pubchem.ncbi.nlm.nih.gov/compound/33624. Accessed July 26, 2022.

Bảo quản
Store between 2-8°C. Opened bottle: Store below 25°C; use within 4 weeks. Protect from light.
Phân loại MIMS
Thuốc trị tăng nhãn áp
Phân loại ATC
S01ED51 - timolol, combinations ; Belongs to the class of beta blocking agents. Used in the treatment of glaucoma.
Tài liệu tham khảo
Anon. Latanoprost and Timolol. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 17/12/2020.

Anon. Latanoprost. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 18/12/2020.

Anon. Timolol (Ophthalmic). Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 18/12/2020.

Buckingham R (ed). Latanoprost. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 17/12/2020.

Buckingham R (ed). Timolol Maleate. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 17/12/2020.

Joint Formulary Committee. Latanoprost with Timolol. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 17/12/2020.

Xalacom 50 mcg/mL + 5 mg/mL, Eye Drops, Solution (Pfizer Ltd). MHRA. https://products.mhra.gov.uk/. Accessed 17/12/2020.

Xalacom Eye Drops, Solution (Pfizer Manufacturing Belgium NV). National Pharmaceutical Regulatory Agency - Ministry of Health Malaysia. https://www.npra.gov.my/. Accessed 17/12/2020.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Latanoprost + Timolol từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2022 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
  • Lacoma-T
  • Xalacom
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in